PTI5803
PRECLINICAL
PHASE 1
PHASE 2
PHASE 3
PRE
P1
P2
P3
Edit
Updated: 04/02/2025
Pipeline Type
New Drugs in Development
Phase Of Development
Phase 1
Sponsors and Collaborators
Panntherapi
Mechanism of Action
Other
Mechanism Description
Pannexin-1 channel blockade: a specific new target which is involved in the genesis of focal seizures (identified uing post-operative brain tisues from patients)
Populations Tested In
N/A
Other Resources
Special FDA Designation
None
Orphan Drug
Nonprofit or Government Support
Government
Nonprofit or Government Support Description
BPI and Europe grants (i-Lab, EIC Accelerator)
Previous Presentations
Location of Clinical Trials
Phase 1: France
Phase 2-3: Europe and US
Clinical Trial link